Šî‘bŠÅŒìŠwuÀ^Œ’N‰ÈŠw—̈æ

 

1D    —̈æ\¬‹³EˆõEÝEŠúŠÔ

‹³Žö

Îè@•Žu

º˜a58”N4ŒŽ`•½¬12”N3ŒŽ@i‘æ3“à‰Èj •½¬12”N4ŒŽ`@@iŒ’N‰ÈŠwj

‹³Žö

d¼@—z‰î

•½¬11”N4ŒŽ`

 

 

 

2D    Œ¤‹†ŠT—v

“à‰È޾г‚ÆŠÅŒìEŒÄ‹zŠí޾г‚ÆŠÅŒì

 

œ       Œ¤‹†ŠT—v

‡@Ý‘îŽ_‘f—Ö@ŽÒ‚Ì‚p‚n‚kŒ¤‹†A‡ACOPD‚ÌQOLŒ¤‹†A‡B‚½‚΂±‹Ö‰Œ‹³ˆçA‡C”xŒŒŠÇ‚m‚n‚r’²ß‹@\‚Ì•ªŽq‰»Šw“IŒ¤‹†A‡D‚’n±‘§“®•¨‚Ì”xzŠÂ“Á«‚ÌŒ¤‹†B
‡@‡A‡B
Šî‘bŠÅŒìŠw‚¨‚æ‚Ñ’nˆæŠÅŒìŠw‚̃Xƒ^ƒbƒt‚ƂƂà‚É•ŸˆäŒ§Ý‘îŽ_‘f—Ö@гŽÒ‰ï‚̉^‰c‚ÉŽæ‚è‘g‚ÝAгŽÒ‚³‚ñ‚ÌŽ‹“_‚©‚ç‚Ì‚p‚n‚k‚Ì•]‰¿‚Ì•û–@‚ð–Íõ‚µ‚Ä‚¢‚éB‚Q‚O‚O‚S”N“x‚©‚ç‚ÍAƒ^ƒoƒR‹i‰Œ‚Ì‚p‚n‚k‚ÌŒ¤‹†‚É‚à’…Žè‚µ‚½B‚»‚̬‰Ê‚ðA–k—¤ŒÄ‹zƒPƒAŒ¤‹†‰ïA“ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïA•Ä‘ŒÄ‹zŠíŠw‰ïi‚`‚s‚rj‚Å”­•\‚µAŠÅŒìŠw‰ÈŠw¶‚Ì‘²˜_‚âCŽm˜_•¶‚Æ‚µ‚Ă܂Ƃ߂ç‚ꂽB2007”N‚©‚ç‚͇A‚𕶉ÈȉȌ¤”ï‚𓾂ÄALINQ‚ð‚à‚Æ‚É‚µ‚ÄŠJŽn‚µ‚½B‚±‚ê‚çˆê˜A‚ÌŒ¤‹†‚Í–{Šw‚Ì’†Šú–Ú•W‚̈ê‚‚ł ‚é•a‚ß‚él‚Ì‚p‚n‚k‚Ì•]‰¿C‰ü‘P‚Ö‚Ì–Íõ‚ɉˆ‚¤‚à‚̂ł ‚éB‚Ü‚½Aƒ^ƒoƒR‹Ö‰Œ‚ÌŠw¶u‹`(ŠÅŒìŠw‰È‚PA2”N¶)‚à‘‡f—Õ”‚ÌŽðˆä“N•væ¶‚Æ‹¤“¯‚ÅŠJŽn‚µA‹Ö‰Œ‹³ˆç•û–@‚ɂ‚¢‚Ă̬‰Ê‚ð‘ۊŌ싳ˆçŠw‰ï‚ÅŠî‘bŠÅŒìŠwƒXƒ^ƒbƒt‚ª”­•\‚µ‚½B
‡C
–{Šw•a‘Ô§ŒäˆãŠwuÀ‚Ƃ̋¤“¯Œ¤‹†‚Å‚ ‚éB‘åŠw‰@¶‚Ì”ŽŽm˜_•¶ƒe[ƒ}‚Æ‚µ‚Ä’áŽ_‘f‚Æ”xzŠÂ”½‰ž‚ð‚m‚n‚rAPGI2‚¨‚æ‚ÑRhoƒLƒi[ƒ[‚ÉÅ“_‚𓖂ĂČŸ“¢i•¶‰ÈȉȊwŒ¤‹†•¬‹à(Šî”ÕC)j‚µAŠwˆÊ˜_•¶‚ƂȂÁ‚½B
‡D
MB‘åŠw‚Ƃ̋¤“¯Œ¤‹†‚̉„’·üã‚Ɉʒu‚µA‰ÈŠwŒ¤‹†•¬‹à(ŠCŠOŠî”ÕB2004`2006”N“x)‚𓾂Ĭ‰Ê“¾‚½‚ªA‚³‚ç‚É2008`2011”N“x‚̉ȊwŒ¤‹†•¬‹à(ŠCŠOŠî”ÕB)‚𓾂Ȥ‹†“WŠJ‚ð}‚Á‚Ä‚¢‚éB

 

œ       ƒL[ƒ[ƒh

Ý‘îŽ_‘f—Ö@, ‚b‚n‚o‚c, ‚½‚΂±‹Ö‰Œ‹³ˆç, ”x‚ŒŒˆ³Ç, ‚’n“K‰ž

 

œ       ‹ÆÑ”N‚Ìi’»ó‹µ

’†‰›ƒAƒWƒA“VŽRŽR–¬‚Ì‚’n‚Ö•‹‚«A‚’n“K‰ž“®•¨‚Ì”xzŠÂ“Á«‚ðŒŸ“¢‚µ‚½Bƒ„ƒN‚̉ESƒJƒe[ƒeƒ‹ŒŸ¸‚ð‚q‚ˆ‚ƒLƒi[ƒ[ƒCƒ““úƒrƒ^[‚ð—p‚¢‚Äs‚Á‚½Œ‹‰ÊA’áŽ_‘fŠÂ‹«‚É‚à‚©‚©‚í‚炸‰½ŒÌƒ„ƒN‚Í”x‚ŒŒˆ³Ç‚ɂȂç‚È‚¢‚Ì‚©‚Ì“š‚¦‚Ì‚Ð‚Æ‚Â‚Í”x‚q‚ˆ‚ƒLƒi[ƒ[‚Ì”­Œ»EŠˆ«’ቺ‚É‚ ‚邯‚¢‚¤Œ‹˜_‚𓾂½B

 

œ       “ÁF“™

‘Û‹¤“¯Œ¤‹†‚ð’Ê‚µ‚ÄA’¼Ú’†‰›ƒAƒWƒA“VŽRŽR–¬‚Ì‚’n‚Ö•‹‚«A‚’n“K‰ž“®•¨‚Ì”xzŠÂ“Á«‚ðŒŸ“¢‚·‚邱‚Ƃɂæ‚Á‚ÄA’áŽ_‘fŠÂ‹«‚É‚à‚©‚©‚í‚炸‰½ŒÌ”x‚ŒŒˆ³Ç‚ɂȂç‚È‚¢‚Ì‚©‚Ì“š‚¦‚ª”x‚m‚n‚rŒn‚̘´i‚Æ”x‚q‚ˆ‚ƒLƒi[ƒ[‚Ì”­Œ»EŠˆ«’ቺ‚É‚ ‚邯‚¢‚¤Œ‹˜_‚𓾂‚‚ ‚éB‚Ü‚³‚ÉA“®•¨‚ª‰½–œ”N‚à‚©‚©‚Á‚‚Ċl“¾‚µ‚½“K‰ž‹@˜iŽ©‘RŠE‚ÌŽÀŒ±Œ‹‰Êj‚ð‚©‚¢‚܂݂½BƒLƒ‹ƒMƒXƒ^ƒ“‚ÌŒ¤‹†ŽÒ‚Æ‚ÌM—ŠŠÖŒW‚à[‚Ü‚èA«—ˆ‰ä‚ª‘‚Ƃ̑ۋ¤“¯Œ¤‹†‚ª•L‚­“WŠJ‚Å‚«‚é‘b‚̈ê•à‚Æ‚à‚Ȃ肦‚éB

 

œ       –{Šw‚Ì—”O‚Ƃ̊֌W

‡@‡A‡B‚Í–{Šw‚Ì’†Šú–Ú•W‚̈ê‚‚ł ‚é•a‚ß‚él‚Ì‚p‚n‚k‚Ì•]‰¿C‰ü‘P‚Ö‚Ì–Íõ‚ɉˆ‚¤‚à‚̂ł ‚éB
‚Ü‚½A‡C‡D‚Ͷ‘̂ɂ¨‚¯‚éî•ñ“`’BE§Œä‹@\‚̉𖾂ð’Ê‚¶A‰ÈŠw‹Zp‚Ì”­“W‚ÉŠñ—^‚·‚é‘Û“IŠwpŒ¤‹†‚Å‚ ‚éB‘Û“I‹¤“¯Œ¤‹†‚¨‚æ‚Ñl“IŒð—¬‚Ì„i‚ÉvŒ£‚µ‚Ä‚¢‚éB

 

¬Ž™Ž¾Š³E¬Ž™ŠÅŒì

 

œ       Œ¤‹†ŠT—v

@ƒ^ƒ“ƒfƒ€Ž¿—Ê•ªÍŒv‚ð—p‚¢‚½V¶Ž™‘ãŽÓˆÙíƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚ÌŽŽŒ±Œ¤‹†i“ú–{ŠwpU‹»‰ï‰ÈŠwŒ¤‹†”ï•â•‹àEŠî”ÕŒ¤‹†(C)(2) ‚¨‚æ‚ÑŒú¶˜J“­È‰ÈŠwŒ¤‹†”ï•â•‹àEŽq‚Ç‚à‰Æ’둇Œ¤‹†Ž–‹Æ‚É‚æ‚éj‚ðŒp‘±‚µ‚½BƒXƒNƒŠ[ƒjƒ“ƒO¸“x‚ð‚‚ß‚éV‚µ‚¢ŒŸ¸–@‚ðŠJ”­‚µA•Ÿˆä‘åŠw¬Ž™‰È‚Å‚ÌŽŽŒ±Œ¤‹†‚Å–ñ‚S‚X–œV¶Ž™‚Ì’†‚©‚ç‚T‚S—á‚ÌŠ³Ž™‚ðf’f‚µAX‚Ɍ㔭‚̃pƒCƒƒbƒgƒXƒ^ƒfƒBŽQ‰Á‹@ŠÖ‚Ö‚Ì‹ZpŽx‰‡‚ðs‚Á‚½B‚±‚ê‚É‚æ‚è‘S‘‚ł̃XƒNƒŠ[ƒjƒ“ƒOŽŽŒ±Œ¤‹†‚͂킪‘V¶Ž™‚Ì–ñ20%‚ð‘ÎÛ‚Æ‚·‚é‹K–͂ƂȂèA‘S‘‹K–͂̃XƒNƒŠ[ƒjƒ“ƒO‘̧‚ð\’z‚µ‚Ä‚¢‚­Šî‘b‚Æ‚·‚邱‚Æ‚ªo—ˆ‚½B‚±‚Ì’†‚ÅA–{”N“x‚Í“Á‚ɃXƒNƒŠ[ƒjƒ“ƒO“ñŽŸŒŸ¸–@‚ɂ‚¢‚ÄŒŸ“¢‚µA‚»‚Ì—L—p«‚ɂ‚¢‚Ä•ñ‚µ‚½Bƒ^ƒ“ƒfƒ€ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚ðŽÀŽ{‚µ‚Ä‚¢‚È‚¢’nˆæ‚É‚¨‚¯‚é“ûŽ™“Ë‘RŽ€—á‚̉ðÍ‚às‚¢AƒXƒNƒŠ[ƒjƒ“ƒO‘ÎÛŽ¾Š³‚ªŒ´ˆö‚Å‚ ‚é•¡”—á‚ðf’f‚µAƒ^ƒ“ƒfƒ€ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒOŽÀŽ{‚̈Ӌ`‚ɂ‚¢‚Ä•ñ‚µ‚½B‚IgDÇŒóŒQƒXƒNƒŠ[ƒjƒ“ƒO‚Ì‚½‚߂̔A’†ƒƒoƒƒ“Ž_’è—Ê–@‚ð•ñ‚µ‚½BX‚ÉAމ–bŽ_Ž_‰»ˆÙíǂ̉»Šwf’f‚¨‚æ‚уtƒ‹ƒNƒg[ƒX1-6ƒrƒXƒtƒHƒXƒtƒ@ƒ^[ƒ[Œ‡‘¹Ç‚Ìy‘ff’f‚̉䂪‘‚É‚¨‚¯‚é’†SŽ{݂Ƃµ‚ÄAˆø‚«‘±‚«‘S‘Še’n‚̈ã—Ë@ŠÖ‚݂̂Ȃ炸AƒCƒ“ƒh‚â’†‘‚ÌŒ¤‹†‹@ŠÖ‚©‚ç‚à•ªÍˆË—Š‚ðŽó‚¯•t‚¯A‘½”‚ÌŠ³ŽÒ‚Ìf’f‚ÉvŒ£‚µ‚½B

 

œ       ƒL[ƒ[ƒh

ˆãŠw, æ“V«Ž¾Š³CŠïŒ`, ‘ãŽÓˆÙíC‰h—{«Ž¾Š³, —\–hˆãŠwˆê”Ê, ŠÅŒìCŠÅŒìƒT[ƒrƒX, V¶Ž™ƒXƒNƒŠ[ƒjƒ“ƒO, ¬’·áŠQ

 

œ       ‹ÆÑ”N‚Ìi’»ó‹µ

@ƒ^ƒ“ƒfƒ€Ž¿—Ê•ªÍŒv‚ð—p‚¢‚½V¶Ž™‘ãŽÓˆÙíƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚ÌŽŽŒ±Œ¤‹†i“ú–{ŠwpU‹»‰ï‰ÈŠwŒ¤‹†”ï•â•‹àEŠî”ÕŒ¤‹†(C)(2) ‚¨‚æ‚ÑŒú¶˜J“­È‰ÈŠwŒ¤‹†”ï•â•‹àEŽq‚Ç‚à‰Æ’둇Œ¤‹†Ž–‹Æ‚É‚æ‚éj‚ðŒp‘±‚µ‚½BƒXƒNƒŠ[ƒjƒ“ƒO¸“x‚ð‚‚ß‚éV‚µ‚¢ŒŸ¸–@‚ðŠJ”­‚µA•Ÿˆä‘åŠw¬Ž™‰È‚Å‚ÌŽŽŒ±Œ¤‹†‚Å–ñ‚S‚X–œV¶Ž™‚Ì’†‚©‚ç‚T‚S—á‚ÌŠ³Ž™‚ðf’f‚µAX‚Ɍ㔭‚̃pƒCƒƒbƒgƒXƒ^ƒfƒBŽQ‰Á‹@ŠÖ‚Ö‚Ì‹ZpŽx‰‡‚ðs‚Á‚½B‚±‚ê‚É‚æ‚è‘S‘‚ł̃XƒNƒŠ[ƒjƒ“ƒOŽŽŒ±Œ¤‹†‚͂킪‘V¶Ž™‚Ì–ñ20%‚ð‘ÎÛ‚Æ‚·‚é‹K–͂ƂȂèA‘S‘‹K–͂̃XƒNƒŠ[ƒjƒ“ƒO‘̧‚ð\’z‚µ‚Ä‚¢‚­Šî‘b‚Æ‚·‚邱‚Æ‚ªo—ˆ‚½B‚±‚Ì’†‚ÅA–{”N“x‚Í“Á‚ɃXƒNƒŠ[ƒjƒ“ƒO“ñŽŸŒŸ¸–@‚ɂ‚¢‚ÄŒŸ“¢‚µA‚»‚Ì—L—p«‚ɂ‚¢‚Ä•ñ‚µ‚½Bƒ^ƒ“ƒfƒ€ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚ðŽÀŽ{‚µ‚Ä‚¢‚È‚¢’nˆæ‚É‚¨‚¯‚é“ûŽ™“Ë‘RŽ€—á‚̉ðÍ‚às‚¢AƒXƒNƒŠ[ƒjƒ“ƒO‘ÎÛŽ¾Š³‚ªŒ´ˆö‚Å‚ ‚é•¡”—á‚ðf’f‚µAƒ^ƒ“ƒfƒ€ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒOŽÀŽ{‚̈Ӌ`‚ɂ‚¢‚Ä•ñ‚µ‚½B‚IgDÇŒóŒQƒXƒNƒŠ[ƒjƒ“ƒO‚Ì‚½‚߂̔A’†ƒƒoƒƒ“Ž_’è—Ê–@‚ð•ñ‚µ‚½BX‚ÉAމ–bŽ_Ž_‰»ˆÙíǂ̉»Šwf’f‚¨‚æ‚уtƒ‹ƒNƒg[ƒX1-6ƒrƒXƒtƒHƒXƒtƒ@ƒ^[ƒ[Œ‡‘¹Ç‚Ìy‘ff’f‚̉䂪‘‚É‚¨‚¯‚é’†SŽ{݂Ƃµ‚ÄAˆø‚«‘±‚«‘S‘Še’n‚̈ã—Ë@ŠÖ‚݂̂Ȃ炸AƒCƒ“ƒh‚â’†‘‚ÌŒ¤‹†‹@ŠÖ‚©‚ç‚à•ªÍˆË—Š‚ðŽó‚¯•t‚¯A‘½”‚ÌŠ³ŽÒ‚Ìf’f‚ÉvŒ£‚µ‚½B

 

œ       “ÁF“™

æ“V‘ãŽÓˆÙíǂ͑½‚­‚ªŠó­Ž¾Š³‚Å‚ ‚èA‚±‚ê‚ç‚ð“KØ‚Éf’fEŽ¡—·‚邯‚¢‚¤‚“x‚Ȉã—Âð’ñ‹Ÿ‚Å‚«‚é‘“àˆã—Ë@ŠÖ‚ÍŒÀ‚ç‚ê‚邪A•Ÿˆä‘åŠwˆãŠw•”¬Ž™‰È‚ƘAŒg‚µ‚Ä‚±‚ê‚ç‚ð‰Â”\‚É‚µ‚Ä‚¢‚éB‚Ü‚½A‘¼‚̈ã—Ë@ŠÖ‚É‚“x‚Èf’f‚ÌŽx‰‡‚ðs‚¢A‚Ü‚½ŒÀ’肵‚½Ž¾Š³ŒQ‚ɑ΂µ‚Ăł ‚é‚ªŽ¡—ÂȂǂ̈ã—Ãî•ñ’ñ‹Ÿ‚às‚Á‚Ä‚¢‚éBf’fŽx‰‡‚ɂ‚¢‚Ä‚ÍA‚»‚ê‚ð•K—v‚Æ‚µ‚Ä‚¢‚éŠO‘‚̈ã—Ë@ŠÖ‚ɑ΂µ‚Ä‚às‚Á‚Ä‚¢‚éB

 

œ       –{Šw‚Ì—”O‚Ƃ̊֌W

¢ŠE…€‚ł̈ãŠwŒ¤‹†‚ð„i‚µAV¶Ž™ƒXƒNƒŠ[ƒjƒ“ƒO‚âæ“V‘ãŽÓˆÙíÇf’fŽx‰‡‚ð’Ê‚¶‚ÄA’nˆæ‚¾‚¯‚łȂ­‘“à‚Ü‚½‘Û“I‚ÈvŒ£‚ðs‚Á‚Ä‚¢‚éB

 

 

 

3D    Œ¤‹†ŽÀÑ

‹æ@@•ª

•Ò@@”

ƒCƒ“ƒpƒNƒgƒtƒ@ƒNƒ^[ (‚¤‚¿Œ´’˜‚Ì‚Ý)

2004`2009”N•ª

2009”N•ª

2004`2009”N•ª

2009”N•ª

˜a•¶Œ´’˜˜_•¶

30

2

\\\\\

\\\\\

‰p•¶˜_•¶

̧°½Äµ°»°

8

0

14.956 ( 14.956)

0.000 ( 0.000)

ºÚ½ÎßÝÃިݸ޵°»°

6

0

11.656 ( 11.656)

0.000 ( 0.000)

‚»‚Ì‘¼

36

8

113.610 ( 113.610)

27.348 ( 27.348)

‡Œv

44

8

128.566 ( 128.566)

27.348 ( 27.348)

 

 

 

iAj      ’˜‘E˜_•¶“™

(1)    ‰p•¶F˜_•¶“™

aDŒ´’˜˜_•¶iR¸—Lj

0978001

*M.Morikawa, *Y.Demura, T.Ishizaki, *S.Ameshima, *I.Miyamori, *M.Sasaki, *T.Tsuchida, *H.Kimura, *Y.Fujibayashi, *H.Okazawa: The Effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax. J Nucl Med, 50i1j, 81-87, 2009.01, #5.915, DOI; 10.2967/jnumed.108.056408

 

0978002

+M.Nakanishi, *Y.Demura, *S.Ameshima, *N.Kosaka, +Y.Chiba, +S.Nishikawa, *H.Itoh, T.Ishizaki: Utility of high-resolution computed tomography for predicting risk of sputum smear-negative pulmonary tuberculosis. Eur J Radiol, 22, 2009.01, #1.915, DOI; doi:10.1016/j.ejrad.2008.12.009

 

0978003

+J.Purevsuren, +H.Kobayashi, +Y.Hasegawa, +Y.Mushimoto, +H.Li, +S.Fukuda, Y.Shigematsu, +T.Fukao, +S.Yamaguchi: A novel molecular aspect of Japanese patients with medium-chain acyl-CoA dehydrogenase deficiency (MCADD): c.449-452delCTGA is a common mutation in Japanese patients with MCADD. Mol Genet Metab, 96i2j, 77-79, 2009.02, #2.550

 

0978004

*S.Mizuno, +Herman J Bogaard, +Norbert F Voelkel, *Y.Umeda, *M.Kadowaki, *S.Ameshima, *I.Miyamori, T.Ishizaki: Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathways. Resp Res, 6i10j, 17, 2009.03, #3.874, DOI; 10.1186/1465-9921-10-17.

 

0978005

*Y.Demura, *T.Tsuchida, *Y.Umeda, +D.Uesaka, *M.Morikawa, *S.Ameshima, T.Ishizaki, *Y.Fujibayashi, *H.Okazawa: Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic responses in patients with pulmonary mycobacteriosis. Eur J Nucl Med Mol Img, 36i4j, 632-639, 2009.04, #4.532, DOI; 10.1007/s00259-008-1009-5

 

0978006

+R.Tsuburaya, +O.Sakamoto, +N.Arai, +H.Kobayashi, +Y.Hasegawa, +S.Yamaguchi, Y.Shigematsu, +M.Takayanagi, +T.Ohura, +S.Tsuchiya: Molecular analysis of a presymptomatic case of carnitine palmitoyl transferase (CPT I) deficiency detected by tandem mass spectrometry newborn screening in Japan. Brain Dev, 2009.04, #1.401

 

0978007

+H.Nagasaka, +Y.Okano, *H.Tsukahara, Y.Shigematsu, +T.Momoi, +J.Yorifuji, +T.Miida, +T.Ohura, +K.Kobayashi, +T.Saheki, +K.Hirano, +M.Takayanagi, +T.Yorifuji: Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin- deficiency even during the silent period. Mol Genet Metab, 97i1j, 21-26, 2009.05, #2.629

 

0978008

*Y.Umeda, *Y.Demura, T.Ishizaki, *S.Ameshima, *I.Miyamori, +Y.Saito, *T.Tsuchida, *Y.Fujibayashi, *H.Okazawa: Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia. Eur J Nucl Med Mol Imaging, 36i7j, 1121-1130, 2009.07, #4.532, DOI; 10.1007/s00259-009-1069-1

 

(2)    ˜a•¶F’˜‘“™iproceedings‚𜂭j

aD’˜‘i•ª’SŽ·•Mj

0978009

d¼@—z‰î: މ–bŽ_‘ãŽÓˆÙíÇ(ƒÀŽ_‰»ŒnjFMeet the Expert: “ú–{æ“V‘ãŽÓˆÙíŠw‰ï(•Ò): Ç—á‚©‚çŠw‚Ôæ“V‘ãŽÓˆÙíÇ, f’f‚ÆŽ¡—ÃŽÐ, 130-131, 2009.07

 

(0878059)

*ŽR“c@{”üœ¨, d¼—z‰î: ¬Ž™ŠÅŒìŠw: “cç²”ü’qŽq(•Ò): 2009”N‹³‰È•ÊŠÅŒìŽt‘‰ÆŽŽŒ±‘Îô–â‘èW, 3, ƒƒfƒBƒJo”Å, 241-268, 2008.08

 

0978010

*ŽR“c@{”üœ¨, d¼—z‰î: ¬Ž™ŠÅŒìŠw: “cç²”ü’qŽq(•Ò): 2010”N‹³‰È•ÊŠÅŒìŽt‘‰ÆŽŽŒ±‘Îô–â‘èW, 4, ƒƒfƒBƒJo”Å, 243-266, 2009.07

 

0978011

d¼@—z‰î, *”¨@ˆè]: ƒtƒ‹ƒNƒg[ƒX1,6ƒrƒXƒzƒXƒtƒ@ƒ^[ƒ[Œ‡‘¹Ç: u¬Ž™“à‰Èvu¬Ž™ŠO‰Èv•ÒWˆÏˆõ‰ï(•Ò): ¬Ž™Ž¾Š³f—Â̂½‚߂̕a‘Ô¶—‚Q, 4, “Œ‹žˆãŠwŽÐ, 415-417, 2009.08

 

(3)    ˜a•¶F˜_•¶“™

aDŒ´’˜˜_•¶iR¸—Lj

0978012

+¬–ì_–¾, +’A”n„, +²‘qL•v, d¼@—z‰î: ƒ^ƒ“ƒfƒ€ƒ}ƒXV¶Ž™ƒXƒNƒŠ[ƒjƒ“ƒO‚Ì”A‘fƒTƒCƒNƒ‹ˆÙíǂɑ΂·‚é—L—p«−OTCŒ‡‘¹Ç‚ð’†S‚Æ‚µ‚Ä−. “ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 19i1j, 29-32, 2009.06

 

0978013

+޵žŠŒõŽs, +”~–{‘½ŠìŽq, +™–{^‹|, +¼‰Y—¢, +“Œ“c‰hŽq, +“nç³—Í, +’†’Ã’‰‘¥, +‹g“c“N–ç, +“à“¡‰x˜Y, d¼@—z‰î, +•½‰ª­O: ’Z½‚R-ƒqƒhƒƒLƒVƒAƒVƒ‹-CoA’E…‘fy‘fŒ‡‘¹Ç‚ƈâ“`Žqf’f‚µ‚½‚P—á. “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 113i11j, 1705-1710, 2009.11

 

bD‘à

0978014

d¼@—z‰î, *”¨@ˆè]: ”ñ—U“±‘̉»ŽŽ—¿’²»‚É‚æ‚éƒ^ƒ“ƒfƒ€ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒO. “ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 19i1j, 11-17, 2009.06

 

0978015

Îú±@•Žu, *”~“c@Kа: ƒTƒ‹ƒRƒCƒh[ƒVƒX‚ÆŒ‹Šj‚Ƌ󓴌`¬”xŠàA‚»‚µ‚ÄCOPD. Ž¡—Êw, 43i9j, 84-85, 2009.09

 

0978016

*”~“c@Kа, *o‘º@–FŽ÷, Îú±@•Žu: ŠÔŽ¿«”x޾г‚É‚¨‚¯‚éDual-time-point 18F-FDG PET‰æ‘œ‚Ì—L—p«. ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 29i395j, 1190-1194, 2009.12

 

cD‚»‚Ì‘¼Œ¤‹†“™ŽÀÑi•ñ‘‚ðŠÜ‚Þj

(0878060)

Îú±@•Žu: ‚—îŽÒS‘©«”x޾г‚ւ̑Έ. “ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ, 18i3j, 2008.12

 

0978017

+²‘q@L•v, +’A”n@„, +”’”ö@Œªˆê˜Y, +’Ѻ@–í—ˆ, +‰ª“c@Œ«, +¼‘º@—T, +¬–ì@_–¾, +’†í@ç‘ã”ü, +“nì@”ü–íŽq, +‹gˆä@ç‘ãŽq, +à_ì@ˆÈs, *”¨@ˆè], d¼@—z‰î: ƒ^ƒ“ƒfƒ€ƒ}ƒXV¶Ž™ƒXƒNƒŠ[ƒjƒ“ƒO‚É‚¨‚¯‚éŠm’èf’fF‘ey‘ff’f+•ªŽqˆâ“`Šw“If’f. •½¬20”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àiŽq‚Ç‚à‚̉ƒ둇Œ¤‹†Ž–‹Æj‘ЇE•ª’SŒ¤‹†•ñ‘, 30-32, 2009.03

 

0978018

d¼@—z‰î: ƒ^ƒ“ƒfƒ€ƒ}ƒX‚É‚æ‚éƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚ÌŒø‰Ê‚ÌŒŸ“¢. •½¬20”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àiŽq‚Ç‚à‚̉ƒ둇Œ¤‹†Ž–‹Æj‘ЇE•ª’SŒ¤‹†•ñ‘, 61-65, 2009.03

 

0978019

d¼@—z‰î, *”¨@ˆè]: •½¬20”N“x‚̃^ƒ“ƒfƒ€ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŽÀÑ‚ÆV‚½‚È“ñŽŸŒŸ¸–@‚É‚æ‚鸓xŒüã‚ÌŒŸ“¢. •½¬20”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àiŽq‚Ç‚à‚̉ƒ둇Œ¤‹†Ž–‹Æj‘ЇE•ª’SŒ¤‹†•ñ‘, 66-68, 2009.03

 

0978020

+¬—Ñ@O“T, +’·’Jì@—L‹I, +’Ž–{@—Yˆê, +ŽRŒû@´ŽŸ, +‘å‰Y@•q”Ž, d¼@—z‰î: “‡ª‘åŠw‚Ås‚Á‚Ä‚¢‚éƒ^ƒ“ƒfƒ€ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŒ¤‹†ó‹µ. •½¬20”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àiŽq‚Ç‚à‚̉ƒ둇Œ¤‹†Ž–‹Æj‘ЇE•ª’SŒ¤‹†•ñ‘, 69-70, 2009.03

 

0978021

+ˆî‰ª@ˆêl, +’|“‡@´”ü, +Š}Œ´@•qŠì, +’†ŽR@‰ëO, +˜a“c@–F’¼, d¼@—z‰î: ƒ^ƒ“ƒfƒ€ƒ}ƒX‚ð—p‚¢‚½V¶Ž™ƒXƒNƒŠ[ƒjƒ“ƒOŒŸ¸ƒf[ƒ^‚̉ðÍE•]‰¿ƒVƒXƒeƒ€‚ÌÝŒv. •½¬20”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àiŽq‚Ç‚à‚̉ƒ둇Œ¤‹†Ž–‹Æj‘ЇE•ª’SŒ¤‹†•ñ‘, 81-84, 2009.03

 

0978022

+“n•Ó@—ÏŽq, +—é–Ø@Œb”üŽq, +•ŸŽm@Ÿ, +–ì’¬@ˉî, +—é–Ø@Œ’, +ΖÑ@M”V, +ŽRã@—SŽŸ, +–؉º@—mŽq, +¬“cØ@³º, +ˆÀ•Ð@‹±Žq, +ˆî“c@‰À”ü, +ÎŽR@—m, +ˆî‰ª@ˆêl, d¼@—z‰î, +¬—Ñ@O“T, +“cè@—²“ñ, +‰Á“¡@’‰–¾, +¼ˆä@—z, +Œ´“c@³•½: ƒ^ƒ“ƒfƒ€ƒ}ƒXƒXƒNƒŠ[ƒ“ƒO‚É‚¨‚¯‚é§“xŠÇ—‚ÌŒ»ói2008”N“xj. •½¬20”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àiŽq‚Ç‚à‚̉ƒ둇Œ¤‹†Ž–‹Æj‘ЇE•ª’SŒ¤‹†•ñ‘, 98-100, 2009.03

 

0978023

+‰Á“¡@’‰–¾, +ˆÀ“¡@ˆŸŠó, +ŒÚ@‰g, +²“¡@‚ä‚«, +’|Œ´@Œ’“ñ, +Œ´“c@³•½, d¼@—z‰î: ¬Ž™–«“Á’èŽ¾Š³Ž¡—ÃŒ¤‹†Ž–‹Æ‚É“o˜^‚³‚ꂽCV‚µ‚¢V¶Ž™ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚Å”­Œ©‚³‚ꂤ‚éŽ¾Š³. •½¬20”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àiŽq‚Ç‚à‚̉ƒ둇Œ¤‹†Ž–‹Æj‘ЇE•ª’SŒ¤‹†•ñ‘, 119-126, 2009.03

 

0978024

Îú±@•Žu: iŠª“ªŒ¾j@¡AŽ„‚½‚¿‚É‹‚ß‚ç‚ê‚Ä‚¢‚é‚à‚Ì‚Í. “ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ, 2009.06

 

0978025

*”~“c@Kа, Îú±@•Žu: ŒÄ‹z«E‘ãŽÓ«ƒAƒVƒh[ƒVƒX. ŒÄ‹zŠíEzŠÂŠíƒPƒA, 9i3j, 18-22, 2009.08

 

0978026

Îú±@•Žu: Ç—á‚©‚ç—‰ð‚·‚éŽ_‰–Šî•½tˆÙí. ŒÄ‹zŠí•zŠÂŠíƒPƒA, 2009.08

 

0978027

Îú±@•Žu: ¼”ö‚çg‹Ö‰Œ‚ɂĒZŠúŠÔ‚ɉü‘P‚µ‘Šú•a•Ï‚Æl‚¦‚ç‚ꂽ”xƒ‰ƒ“ƒQƒ‹ƒnƒ“ƒX×–E‘gD‹…Ç‚Ì1—áh. ‹CŠÇŽxŠw, 2009.09

 

0978028

Îú±@•Žu: •ÒWˆÏˆõ‚¾‚æ‚è. Œ‹Šj, 84i12j, 812, 2009.12

 

 

 

iBj      Šw‰ï”­•\“™

(1)    ‘ÛŠw‰ï

aDˆê”Êu‰‰iŒû‰‰j

0978029

*T.G.Lohith, *T.Kudo, *I.Miyamori, *Y.Demura, *S.Ameshima, T.Ishizaki, *Y.Fujibayashi, *H.Okazawa: Intratumoral distribution pattern of FDG and Cu-62 ATSM in lung cancer patients using PET, Society of Nuclear Medicine, the 56th Annual Meeting, 2009.06, Toronto (Canada), The Journal of Nuclear Medicine, 50iSuppl. 2j, 58P, 2009.06

 

0978030

+Y.Okano, +H.Nagasaka, Y.Shigematsu, *H.Tsukahara, +T.Momoi, +T.Yorifuji, +T.Ohura, +T.Miida, +K.Hirano, +K.Kobayashi, +T.Saheki, +M.Takayanagi: Hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in the patients with citrin deficiency during the silent period, 11th International Congress of Inborn Errors of Metabolism, 2009.09, California

 

0978031

+B Kojonazarov, +M Kasymbekova, +M Wilkins, T.Ishizaki, +A Aldashev: Effects of Rho-kinase inhibitor fasudil on pulmonary arterial pressure in highlanders with high altitude pulmonary hypertension (Double-blind placebo-controlled study, annual meeting of European Resipiratory Society, 2009.09, Vienna, ERJ, 34iAbstract issuesj, 317, 2009.09

 

0978032

Y.Shigematsu, *I.Hata: Useful methods for second-tier analysis in newborn screening of isovaleric acidemia and methylmalonic acidemia by tandem mass spectrometry, 7th International and Latin American Congress of Inborn Errors of Metabolism and Neonatal Screening, 2009.12, Cancun, Mexico, Proceedings of the 7th International and Latin American Congress Inborn Errors of Metabolism and Neonatal Screening, 29, 2009.12

 

bDˆê”Êu‰‰iƒ|ƒXƒ^[j

(0878061)

*Y.Umeda, *S.Mizuno, *K.Hattori, *Y.Sumita, *M.Morikawa, *D.Uesaka, *Y.Demura, *S.Ameshima, *I.Miyamori, *H.Naiki, T.Ishizaki: Tumor suppressor p53 attenuates hypoxic pulmonary arterial remodeling, American Thoracic Society International Conference, 2008.05, Tronto Canada

 

0978033

*Y.Uehara, *T.Hasegawa, *Eiichi Ueno, *M.Sasaki, *Kanae@Yoshida, *Edmont C Katz, +Reiko Ueki, T.Ishizaki, +Rie Kashihara: Smoking prevention intervention to improve nursing students' knowledge and attitude, 20th International Network for Education in Healthcare Conference, 2009.09, Cambridge, Abstracts for Theme@PosterCSymposia and Posters, 231, 2009.09

 

(2)    ‘“àŠw‰ïi‘S‘ƒŒƒxƒ‹j

aDµ‘ÒE“Á•Êu‰‰“™

0978034

d¼@—z‰î: ƒ^ƒ“ƒfƒ€ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒO‚É‚¨‚¯‚é‘ÎÛŽ¾Š³‚Æ‚»‚̃XƒNƒŠ[ƒjƒ“ƒO–@, ‘æ51‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï, 2009.11, “Œ‹ž, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 25i2j, 66, 2009.09

 

bDƒVƒ“ƒ|ƒWƒXƒgEƒpƒlƒŠƒXƒg“™

0978035

Îú±@•Žu, +ÎŒ´‰pŽ÷: Ý‘îŒÄ‹zƒPƒA‚ƃrƒ‡ƒEƒVƒ“˜AŒg[¡Œã‚Ì“W–][, “ú–{ŒÄ‹zŠíŠw‰ï‘‰ï, Ý‘îŒÄ‹zƒPƒA‚ƃrƒ‡ƒEƒVƒ“˜AŒg[¡Œã‚Ì“W–][, 2009.06, “Œ‹ž, ‚S‚Vi‘Ч†j, ‚P‚U‚, 2009

 

0978036

d¼@—z‰î, *”¨@ˆè]: ƒpƒCƒƒbƒgƒXƒ^ƒfƒB‚©‚猩‚½ƒ^ƒ“ƒfƒ€ƒ}ƒXV¶Ž™ƒXƒNƒŠ[ƒjƒ“ƒO‚Ìd—v«‚Æ¡Œã‚̉ۑè, ‘æ36‰ñ“ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ï, ƒ^ƒ“ƒfƒ€ƒ}ƒX‚É‚æ‚éV¶Ž™ƒXƒNƒŠ[ƒjƒ“ƒOƒVƒXƒeƒ€‚Ì‘S‘“WŠJ, 2009.08, ŽD–yŽs, “ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 19i2j, 128, 2009.08

 

0978037

d¼@—z‰î, *”¨@ˆè], +ˆî‰ª@ˆêl, +–ì’¬@ˉî, +ΖÑ@M”V: ƒ^ƒ“ƒfƒ€ƒ}EƒXƒXƒNƒŠ[ƒjƒ“ƒO‚É‚¨‚¯‚é‘ÎÛŽ¾Š³f’f‰ß’ö‚É‚¨‚¯‚éi“W, ‘æ34‰ñ“ú–{ˆã—pƒ}ƒXƒXƒyƒNƒgƒ‹Šw‰ï, MS‚̉ž—pF“Å«•]‰¿‚©‚çŒÂ•ʉ»ˆã—Â܂Å, 2009.09, ‘åãŽs, JSBMS Letters, 34(Suppl), 28, 2009.08

 

0978038

Îú±@•Žu, +“y‹—mŽq: ŒÄ‹zƒPƒA”F’èŠÅŒìŽti‰¼Ìj§“x‚Ì”­‘«‚ÉŒü‚¯‚Ä@Ži‰ï‚ÌŒ¾—t, “ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï‘‰ï, ŒÄ‹zƒPƒA”F’èŠÅŒìŽti‰¼Ìj§“x‚Ì”­‘«‚ÉŒü‚¯‚Ä, 2009.10, “Œ‹ž, ‚P‚XiSupplj, ‚W‚P‚“, 2009.10

 

0978039

*Xì@”ü‰H, *”~“c@Kа, +ãâ@‘¾—S, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu: lHŒÄ‹zŠÇ—‚ð—v‚µ‚½‚—îŽÒ‹CŠÇŽxšb‘§dÏ”­ì‚Ì3—á, ‘æ59‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï, 2009.10, H“c

 

0978040

d¼@—z‰î: ‚킪‘‚É‚¨‚¯‚éƒ^ƒ“ƒfƒ€ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŽŽŒ±Œ¤‹†‚ÌŒ»ó‚Ɖۑè, ‘æ51‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï, ƒ^ƒ“ƒfƒ€ƒ}ƒX“±“ü‚É‚æ‚éV¶Ž™ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚ÌVŽž‘ã, 2009.11, “Œ‹ž, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 25i2j, 60, 2009.09

 

cDˆê”Êu‰‰iŒû‰‰j

0978041

+¼‰Y@”Í•v, +lŒ©@•q–¾, +Œ´“c@_“ñ, d¼@—z‰î, +¬ò@º•v: ‘Sg«ƒJƒ‹ƒjƒ`ƒ“Œ‡‘¹Ç‚É”F‚ß‚ç‚ꂽsplicingˆÙí, ‘æ79‰ñ“ú–{‰q¶Šw‰ïŠwp‘‰ï, 2009.03, “Œ‹ž, “ú–{‰q¶ŠwŽGŽ, 64i2j, 490, 2009.02

 

0978042

+¬—Ñ@O“T, +’·’Jì@—L‹I, +’Ž–{@—Yˆê, +ŽRŒû@´ŽŸ, d¼@—z‰î: ƒ^ƒ“ƒfƒ€ƒ}ƒX‚É‚æ‚éV¶Ž™ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒO”­Œ©—á‚Æ”­ÇŒãf’f—á‚Ì—Õ°‘œ‚ÌŒŸ“¢, ‘æ112‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï, 2009.04, “Þ—ÇŽs, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 113i2j, 435, 2009.02

 

0978043

+‘å¼@’B–ç, +X@ˆê”Ž, +ŠÝ@—gŽq, +‚¼@¹“¿, +ŽRã@‹MŽi, +ŽR‰º@˜aŽq, +¼‰ª@—D, d¼@—z‰î, +â–{@C, +ˆÉ“¡@“¹“¿: ”A’†ƒPƒgƒ“‘̉A«E‚ŒŒ“œ‚ð’æ‚µ‚½V‹K•ψقɂæ‚郃`ƒ‹ƒ}ƒƒ“Ž_ŒŒÇ‚̈ê—á, ‘æ112‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï, 2009.04, “Þ—ÇŽs, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 113i2j, 330, 2009.02

 

0978044

+ŽR–{@»Žq, +¼–{@Žu˜Y, +Šâˆä@³Œ›, +‰¡ŽR@WŽq, d¼@—z‰î, +ŽOŸº@_: “ú—î2‚É”­Ç‚µ“Ë‘RŽ€‚ð‰ñ”ð‚µ“¾‚½ÅdÇŒ^Ž‰Ž¿‘ãŽÓˆÙíÇ‚Ì1V¶Ž™—á, ‘æ23‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ï, 2009.06, ŒF–{Žs, “ú–{¬Ž™‹~‹}ˆãŠw‰ïŽGŽ, 8, 181, 2009.05

 

0978045

+“n•Ó@—ÏŽq, +—é–Ø@Œb”üŽq, +Œ´“c@³•½, +‰Á“¡@’‰–¾, +¼ˆä@—z, +•ŸŽm@Ÿ, +—é–Ø@Œ’, +ŽRã@—SŽŸ, +¬“cØ@³º, +ˆÀ•Ð@‹±Žq, +ÎŽR@—m, +ˆî‰ª@ˆêl, d¼@—z‰î, +¬—Ñ@O“T, +“cè@—²“ñ: ƒ^ƒ“ƒfƒ€ƒ}ƒXƒXƒNƒŠ[ƒ“ƒO‚É‚¨‚¯‚é§“xŠÇ—‚ÌŒŸ“¢i‘æ‚Q•ñj, ‘æ36‰ñ“ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ï, 2009.08, ŽD–yŽs, “ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 19i2j, 136, 2009.08

 

0978046

d¼@—z‰î, *”¨@ˆè]: ƒ^ƒ“ƒfƒ€ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO“ñŽŸŒŸ¸–@‚Æ‚µ‚Ä‚ÌGC/MS‚É‚æ‚é‚뎆ŒŒ’†ƒƒ`ƒ‹ƒ}ƒƒ“Ž_•ªÍ, ‘æ36‰ñ“ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ï, 2009.08, ŽD–yŽs, “ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 19i2j, 157, 2009.08

 

0978047

+’A”n@„, +²‘q@L•v, +’Ѻ@–í—ˆ, +Œ´@Œ\ˆê, +”’”ö@Œªˆê˜Y, +‰ª“c@Œ«, +¼‘º@—T, +¬–ì@_–¾, +’†í@ç‘ã”ü, +“nì@”ü–íŽq, +‹gˆä@ç‘ãŽq, +à_ì@ˆÈs, *”¨@ˆè], d¼@—z‰î: L“‡Œ§‚É‚¨‚¯‚éƒ^ƒ“ƒfƒ€ƒ}ƒXV¶Ž™ƒXƒNƒŠ[ƒjƒ“ƒO10”NŠÔ‚ÌŒoŒ±, ‘æ36‰ñ“ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ï, 2009.08, ŽD–yŽs, “ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 19i2j, 163, 2009.08

 

0978048

*à_–ì@’‰‘¥, +•“¡‘½’ØY, Îú±•Žu, *•Ä“c@½, *ŒIŽR@Ÿ: is«‚Ì”’Ž¿•a•ς𗈂µŽ€–S‚µ‚½GoodÇŒóŒQ‚Ì1—á, ‘æ14‰ñ“ú–{_ŒoŠ´õÇŠw‰ï‘‰ï, 2009.10, ‰F“s‹{Žs, NEUROINFECTION _ŒoŠ´õÇ, 14i2j, 163, 2009.10

 

0978049

+–xì@—æŽq, +’†‘º@Œör, +‘å‰Y@•q”Ž, d¼@—z‰î, +ˆË“¡@‹œ, +Š}Œ´@ŒQ¶, +ˆÉ“¡@Gˆê, +Ä“¡@º•F, +‰““¡@•¶•F: ”A‘fƒTƒCƒNƒ‹ˆÙíÇA—L‹@Ž_‘ãŽÓˆÙíÇAŠÌŒ^“œŒ´•a‚É‚¨‚¯‚éŠÌˆÚAŽ¡—ÃŽwj‚Ìì¬, ‘æ51‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï, 2009.11, “Œ‹ž, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 25i2j, 92, 2009.09

 

0978050

d¼@—z‰î, *”¨@ˆè], +’A”n@„, +“à“¡@‰x—Y, +‘å‰Y@•q”Ž: d…•Wޝމ–bŽ_•‰‰×Œã‚Ì––½ƒŠƒ“ƒp‹…’†ƒAƒVƒ‹ƒJƒ‹ƒjƒ`ƒ“•ªÍ‚É‚æ‚鎉–bŽ_Ž_‰»ˆÙíÇf’f–@‚ÌŒŸ“¢i‘æ‚Q•ñj, ‘æ51‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï, 2009.11, “Œ‹ž, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 25i2j, 141, 2009.09

 

0978051

+‹ààV@³Ž÷, +‰Á“¡@‚¢‚¸‚Ý, +áÁŽR@‹`–¯, +‘ºŽR@Œ\, +’·â@”Ž”Í, +‚–ö@³Ž÷, +â–{@C, +¼Œ´@—mˆê, d¼@—z‰î: ˆê‰ß«‚Ì‚ƒgƒŠƒOƒŠƒZƒŠƒhŒŒÇ‚ð’æ‚µ‚½ƒJƒ‹ƒjƒ`ƒ“ƒpƒ‹ƒ~ƒgƒCƒ‹ƒgƒ‰ƒ“ƒXƒtƒFƒ‰[ƒ[‡UŒ‡‘¹Ç‚Ì‚P—á, ‘æ51‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï, 2009.11, “Œ‹ž, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 25i2j, 145, 2009.11

 

0978052

+”’”ö@Œªˆê˜Y, +’A”n@„, +²‘q@L•v, *”¨@ˆè], d¼@—z‰î: SCADŒ‡‘¹Ç‚Ìpathogenesis‚ÌŒŸ“¢, ‘æ51‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï, 2009.11, “Œ‹ž, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 25i2j, 148, 2009.11

 

0978053

+ŽR–{@»Žq, +¼–{@Žu˜Y, +Šâˆä@³Œ›, +ŽO•£@_, +‰““¡@•¶•v, d¼@—z‰î, +’A”n@„: “ú—î‚Q‚ÉSŽº×“®‚Å”­Ç‚µ‹~–½‚Å‚«‚½VLCADŒ‡‘¹Ç‚Ì1—á, ‘æ51‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï, 2009.11, “Œ‹ž, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 25i2j, 148, 2009.09

 

dDˆê”Êu‰‰iƒ|ƒXƒ^[j

0978054

*Žºˆä@—mŽq, Îú±@•Žu, *Šâ“c@_Žq: ŠÅŒìŽt‚ÌŠ´õ—\–hs“®‚ÆŠ´õÇ‚ÌƒŠƒXƒNƒCƒ[ƒW‚ÌŒŸ“¢, “ú–{ŠÂ‹«Š´õŠw‰ï, 2009.02

 

0978055

*”~“c@Kа, +o‘º@–FŽ÷, *Xì@”ü‰H, *’|“c@Ø•äŽq, *ÎŒ´@Tˆê˜Y, *Z“c@‘×”V, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu: ”x–ìŒ^ƒTƒ‹ƒRƒCƒh[ƒVƒX‚É‚¨‚¯‚édual-time point 18F-FDG PETimaging‚Ì—L—p«‚ÌŒŸ“¢, ‘æ49‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï, 2009.06, “Œ‹ž

 

0978056

*Xì@”ü‰H, +o‘º@–FŽ÷, *”~“c@Kа, +ãâ@‘¾—S, *’|“c@Ø•äŽq, *Z“c@‘×”V, *ÎŒ´@Tˆê˜Y, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu, *²X–Ø@³l: ‹¹•”ƒŠƒ“ƒpßf’f‚É‚¨‚¯‚é18F-FDG PET/CT‚ÆSTIR MR‰æ‘œ‚Ì—L—p«, ‘æ49‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï, 2009.06, “Œ‹ž

 

0978057

d¼@—z‰î, *”¨@ˆè], +Žðˆä@G­, +”ªŠp@‚—T, +•½‰Æ@r’j, +¼¬X@—²‘¾: IgDÇŒóŒQƒXƒNƒŠ[ƒjƒ“ƒO‚Ì‚½‚߂̔A’†ƒƒoƒƒ“Ž_’è—Ê, ‘æ34‰ñ“ú–{ˆã—pƒ}ƒXƒXƒyƒNƒgƒ‹Šw‰ï, 2009.09, ‘åãŽs, JSBMS Letters, 34(Suppl), 73, 2009.08

 

0978058

*㌴@‰ÀŽq, *’·’Jì@’qŽq, d¼@—z‰î, *Šâ“c@_Žq: ŠÅŒìŽtŠw‚Ñ’¼‚µƒvƒƒOƒ‰ƒ€‚̃AƒEƒgƒJƒ€•]‰¿`öÝŠÅŒìŽt‚ÆA‹ÆŠÅŒìŽt‚ÌŠwKƒj[ƒY‚Æ‘ŠŒÝŠwKŒø‰Ê‚©‚ç‚ÌŒŸ“¢`, ‘æ40‰ñ“ú–{ŠÅŒìŠw‰ï|ŠÅŒìŠÇ—|ŠwpW‰ï, 2009.10, ‘åãŽs, ´˜^W, 97, 2009.10

 

0978059

*²X–Ø@³l, +ìç²@³˜a, *‰ª“c@WÄ, *¶‹ß@‰À‘ã, *’r“c@ŠxŽj, *•½ˆä@½–ç, *Xì@”ü‰H, +o‘º@–FŽ÷, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu: Šà«‹¹–Œ‰Š‚𗈂½‚µ‚½”ñ¬×–E”xŠà‚ɑ΂·‚鋹o“àƒpƒNƒŠƒ^ƒLƒZƒ‹’“ü—Ö@i—Õ°‘æ‡T‘ŠŽŽŒ±KCOGT-0406j, ‘æ50‰ñ“ú–{”xŠàŠw‰ï, 2009.11, “Œ‹ž, ”xŠà, 49i5j, 745, 2009.10

 

(3)    ‘“àŠw‰ïi’nˆæƒŒƒxƒ‹j

aDˆê”Êu‰‰iŒû‰‰j

(0878062)

+“à“¡@‰x—Y, +¬’J@—T”üŽq, +”ü@Ë“ñ, d¼@—z‰î: Å‹ß4”NŠÔ‚ňâ“`Žqf’f‚µ‚½æ“V‘ãŽÓˆÙíÇ30—á‚Ì—Õ°‘œ, ‘æ131‰ñ“ú–{¬Ž™‰ÈŠw‰ï“¿“‡’n•û‰ï, 2008.12, “¿“‡Žs

 

0978060

*ÎŒ´@Tˆê˜Y, *Z“c@‘×”V, *’|“c@Ø•äŽq, *Xì@”ü‰H, *”~“c@Kа, *o‘º@–FŽ÷, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu: ¬”]ޏ’²Ç‚Å”­Ç‚µAŽîᇔºÇŒóŒQ‚ª‹^‚í‚ꂽ¬×–E”xŠà‚Ì1—á, ‘æ59‰ñ“ú–{”xŠàŠw‰ï–k—¤Žx•”‰ï, 2009.02, ‹à‘ò

 

0978061

*Z“c@‘×”V, *ÎŒ´@Tˆê˜Y, *’|“c@Ø•äŽq, *”~“c@Kа, *Xì@”ü‰H, *o‘º@–FŽ÷, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu, *ûü–Ø@˜a‹M: ¬×–E”xŠàŠ®‘Sа‰ðŒã‚É”­Ç‚µ‚½Primary@effusion@lymphoma‚Ì1—á, ‘æ59‰ñ“ú–{”xŠàŠw‰ï–k—¤Žx•”‰ï, 2009.02, ‹à‘ò

 

0978062

*‰ª“c@WÄ, *²X–Ø@³l, *¶‹ß@‰À‘ã, *’r“c@ŠxŽj, *•½ˆä@½–ç, *Xì@”ü‰H, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu, *¡‘º@DÍ: “ÁˆÙ‚ÈŒ`‘Ô‚ðŽ¦‚µ‚½—tŠÔ‹¹–Œ”­¶‚ÌSolitary Fibrous Tumor‚Ì‚PØœ—á, ‘æ59‰ñ“ú–{”xŠàŠw‰ï–k—¤Žx•”‰ï, 2009.02

 

0978063

*”~“c@Kа, *’|“c@Ø•äŽq, *Z“c@‘×”V, *ÎŒ´@Tˆê˜Y, *Xì@”ü‰H, *ˆÀÖ@³Ž÷, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu, *²X–Ø@³l, *ˆîˆä@–M”Ž, *“à–Ø@G‰„, *ˆÉ“¡@tŠC: ”x‘BŠà‚ÆŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½”x–ìŒ^ƒTƒ‹ƒRƒCƒh[ƒVƒX‚̈ê—á, ‘æ62‰ñŒÄ‹zŠí‡“¯–k—¤’n•û‰ï, 2009.05, VŠƒ

 

0978064

*ÎŒ´@Tˆê˜Y, *”~“c@Kа, *’|“c@Ø•äŽq, *Z“c@‘×”V, *Xì@”ü‰H, *ˆÀÖ@³Ž÷, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu, *²X–Ø@³l, *“à–Ø@G‰„, +”\“oŒ´@Œ›Ži, +•Ÿ‰ª@‡–ç: IgG4ŠÖ˜AŠÔŽ¿«”x‰Š‚̈ê—á, ‘æ62‰ñŒÄ‹zŠí‡“¯–k—¤’n•û‰ï, 2009.05, VŠƒ

 

0978065

*’|“c@Ø•äŽq, *Z“c@‘×”V, *ˆÀÖ@³Ž÷, *Xì@”ü‰H, *”~“c@Kа, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu, *¶‹ß@‰À‘ã, *’r“c@ŠxŽj, *²X–Ø@³l, *ŽR–{@‰p”V, *“¡Ž}@dŽ¡, *¡‘º@DÍ: ‹CŠÇŽx“àÄ”­‚ð‚«‚½‚µ‚½bó‘BŠà‚̈ê—á, ‘æ60‰ñ“ú–{”xŠàŠw‰ï–k—¤Žx•”‰ï, 2009.07, •ŸˆäŽs, ”xŠà, 49i4j, 498-499, 2009.08

 

0978066

*”~“c@Kа, *’|“c@Ø•äŽq, *Z“c@‘×”V, *ÎŒ´@Tˆê˜Y, *Xì@”ü‰H, *ˆÀÖ@³Ž÷, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu, *²X–Ø@³l, *ˆîˆä@–M”Ž, *“à–Ø@G‰„, *ˆÉ“¡@tŠC: ”x‘BŠà‚ÆŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½”x–ìŒ^ƒTƒ‹ƒRƒCƒh[ƒVƒX‚̈ê—á, ‘æ63‰ñŒÄ‹zŠí‡“¯–k—¤’n•û‰ï, 2009.11, •xŽR

 

0978067

*ˆÀÖ@³Ž÷, *’|“c@Ø•äŽq, *Z“c@‘×”V, *Xì@”ü‰H, *”~“c@Kа, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu, +ŒE@½‘¾, *¬£@‹M”V, *¡‘º@DÍ: ƒuƒ‰•Ç“à“]ˆÚ‚𗈂½‚µAVBN+‹É׌a‹CŠÇŽx‹¾‚É‚Äf’f‚̂‚¢‚½Abó‘B–¢•ª‰»Šà”x“]ˆÚ‚̈ê—á, ‘æ63‰ñŒÄ‹zŠí‡“¯–k—¤’n•û‰ï, 2009.11, •xŽR

 

(4)    ‚»‚Ì‘¼‚ÌŒ¤‹†‰ïEW‰ï

aDˆê”Êu‰‰iŒû‰‰j

0978068

*‹gì@—˜‰p, *”¨@ˆè], *‹“c@®Žq, *áÁ‹|@Œõ•¶, d¼@—z‰î: ƒoƒZƒhƒE•a•ê‘Ì‚©‚ço¶‚µAˆê‰ß«’†•«bó‘B‹@”\’ቺǂÆl‚¦‚ç‚ꂽˆê—á, ‘æ23‰ñ–k—¤¬Ž™“à•ª”匤‹†‰ï, 2009.01, ‹à‘òŽs

 

0978069

*ÎŒ´@Tˆê˜Y, *’|“c@Ø•äŽq, *Z“c@‘×”V, *Xì@”ü‰H, *”~“c@Kа, *–å˜e@–ƒˆßŽq, *ˆÀÖ@³Ž÷, *ˆ¹“ˆ@œÄŒá, Îú±@•Žu: ”­”MAŠÖß’ÉA”­]‚Å”­Ç‚µA”xƒXƒŠƒKƒ‰ƒX‰eADICAŠÌ‹@”\áŠQ‚ð‚«‚½‚µ‚½‚P—á, ‘æ462‰ñ•ŸˆäŒ§“à‰È—Õ°§˜b‰ï, 2009.04, •Ÿˆä

 

bDˆê”Êu‰‰iƒ|ƒXƒ^[j

0978070

*”~“c@Kа, *o‘º@–FŽ÷, *Xì@”ü‰H, *–å˜e@–ƒˆßŽq, *ˆ¹“ˆ@œÄŒá, *‰ª‘ò@G•F, *“¡—Ñ@N‹v, Îú±@•Žu: “Á”­«ŠÔŽ¿«”x‰Š‚É‚¨‚¯‚édual-time point FDG-PET imaging ‚Ì—L—p«‚ÌŒŸ“¢, ‘æ1‰ñŒÄ‹z‹@”\ƒCƒ[ƒWƒ“ƒOŒ¤‹†‰ïŠwpW‰ï, 2009.01, ‹ž“s, ´˜^W, 64

 

cD‚»‚Ì‘¼

0978071

*’ËŒ´@Gˆê, d¼@—z‰î: ¶‘̃}[ƒJ[‚ð—p‚¢‚½—Õ°•a‘Ô‚Ì•]‰¿–@‚ÌŠJ”­, Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹àiVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒ“ƒU“™V‹»EÄ‹»Š´õÇŒ¤‹†Ž–‹Æj: ƒCƒ“ƒtƒ‹ƒGƒ“ƒU”]ǂȂÇdǃCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì”­Ç‹@˜‚̉𖾂Ƃ»‚ê‚ÉŠî‚Â­Ž¡—Ö@A—\–h–@‚ÌŠm—§‚ÉŠÖ‚·‚錤‹† - •½¬21”N“x‘æ1‰ñ”ljï‹c, 2009.08, “Œ‹ž

 

 

 

4D    ƒOƒ‰ƒ“ƒgŽæ“¾@@

iAj      ‰ÈŒ¤”ïEŒ¤‹†•¬‹à“™

‹æ•ª

Œ¤‹†Ží–Ú

‰Û@‘è@–¼

‘ã•\ŽÒ–¼

•ª’SŽÒ–¼

Šú@ŠÔ

i”N“xj

‹à@Šz

i”z•ªŠzj

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(B)iŠCŠOŠwp’²¸j

”ñŒöŠJ

Îú±@•Žu

 

2009

4,680ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(C)iˆê”Êj

ƒ^ƒ“ƒfƒ€Ž¿—Ê•ªÍV¶Ž™ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚̸“xŒüã–@ŠJ”­‚Æ—L—p«‚ÌŒ¤‹†

d¼@—z‰î

 

2009

1,040ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(C)iˆê”Êj

ŠÅŒìŠw¶‚Ì‹i‰Œs“®ŠëŒ¯“x—\‘ªŽÚ“x‚ÌŠJ”­‚Æ‹i‰Œ–hŽ~‹³ˆçƒvƒƒOƒ‰ƒ€‚Ì\’z

*㌴@‰ÀŽq

Îú±@•Žu

2009

650ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†(C)iˆê”Êj

‚b‚n‚o‚cгŽÒ‚Ìî•ñƒj[ƒY‚ɑΉž‚µ‚½ƒZƒ‹ƒtƒPƒA”\—ÍŒüã‚Ì‚½‚߂̋³ˆçƒvƒƒOƒ‰ƒ€‚Ì\’z

Îú±@•Žu

 

2009

1,170ç‰~

•¶•”‰ÈŠwȉȊw

Œ¤‹†”ï•â•‹à

Šî”ÕŒ¤‹†i‚ajiˆê”Êj

ˆ««‹y‚Ñ”ñŽîᇫΖȊ֘A޾г‚̃XƒNƒŠ[ƒjƒ“ƒO–@‚ÌÄŒŸ“¢

+›À@¬•¶

Îú±@•Žu

2009

195ç‰~

Œú¶˜J“­È‰ÈŠw

Œ¤‹†”ï•â•‹à

Žq‚Ç‚à‰Æ’둇Œ¤‹†Ž–‹Æ

ƒ^ƒ“ƒfƒ€ƒ}ƒX“™‚ÌV‹Zp‚𓱓ü‚µ‚½V‚µ‚¢V¶Ž™ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‘̧‚ÌŠm—§‚ÉŠÖ‚·‚錤‹†

+ŽRŒû@´ŽŸ

d¼@—z‰î

2009

3,000ç‰~

Œú¶˜J“­È‰ÈŠw

Œ¤‹†”ï•â•‹à

“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ

—L‹@Ž_‘ãŽÓˆÙíÇiƒƒ`ƒ‹ƒ}ƒƒ“Ž_ŒŒÇEƒvƒƒsƒIƒ“Ž_ŒŒÇjA”A‘fƒTƒCƒNƒ‹ˆÙíÇiCPS1, OTCŒ‡‘¹ÇjAŠÌŒ^“œŒ´•a‚ÌV‹KŽ¡—Ö@‚ÌŠm—§‚Æ•W€‰»

+–xì@—æŽq

d¼@—z‰î

2009

2,000ç‰~

Œú¶˜J“­È‰ÈŠw

Œ¤‹†”ï•â•‹à

“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ

IgDÇŒóŒQ‚ɑ΂·‚é×–E•ªŽq¶•¨Šw“IŽè–@‚ð‹ìŽg‚µ‚½f—Êî”Õ‹Zp‚ÌŠJ”­

+•½‰Æ@r’j

d¼@—z‰î

2009

1,000ç‰~

Œú¶˜J“­È‰ÈŠw

Œ¤‹†”ï•â•‹à

“«Ž¾Š³Ž•žŒ¤‹†Ž–‹Æ

æ“V«ƒPƒgƒ“‘Ì‘ãŽÓˆÙíÇiƒÀ-ƒPƒgƒ`ƒIƒ‰|ƒ[Œ‡‘¹ÇAƒTƒNƒVƒjƒ‹-CoA:3-ƒPƒgŽ_CoAƒgƒ‰ƒ“ƒXƒtƒFƒ‰|ƒ[Œ‡‘¹Çj‚Ì”­ÇŒ`‘Ô‚ÆŠ³ŽÒ”‚Ì”cˆ¬Af’fŽwj‚Ì쬂Ɋւ·‚錤‹†

+[”ö@•qK

d¼@—z‰î

2009

1,000ç‰~

 

 

 

iBj      §ŠwŠñ•‹à

Žó“üŒ”

14@Œ

Žó“ü‹àŠz

4,682,925@‰~

 

 

 

5D    ‚»‚Ì‘¼‚ÌŒ¤‹†ŠÖ˜AŠˆ“®

iAj      Šw‰ïŠJÓ™

‹æ•ª

ŽåÃE‹¤Ã‚Ì•Ê

Šw‰ï–¼

ŠJÓú

ŠJÃ’n

‘“àŠw‰ï(’n•ûƒŒƒxƒ‹)

ŽåÃŽÒ

‘æ2‰ñ“ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï–k—¤Žx•”‰ï

2009.03.28

‹à‘òŽs

‘“àŠw‰ï(’n•ûƒŒƒxƒ‹)

ŽåÃŽÒ

‘æ70‰ñ–k—¤Ž¿—Ê•ªÍ’k˜b‰ï

2009.11.21

•ŸˆäŽs

‚»‚Ì‘¼‚ÌŒ¤‹†W‰ï

ŽåÃŽÒ

‘æ7‰ñ@–k—¤Š´õÇŒ¤‹†‰ï

2009.03.14

‹à‘òŽs

‚»‚Ì‘¼‚ÌŒ¤‹†W‰ï

ŽåÃŽÒ

Žá‹·˜p”xƒJƒ“ƒtƒ@ƒŒƒ“ƒX

2009.09.26

•ŸˆäŒ§“Ö‰êŽs

 

 

 

iBj      Šw‰ï‚ÌŽÀÑ

Šw‰ï‚Ì–¼Ì

–ðE–¼

Ž–¼

ƒTƒ‹ƒRƒCƒh[ƒVƒXŠw‰ï

—Ž–

Îè@•Žu

“ú–{Œ‹Šj•aŠw‰ï

‹³ˆçˆÏˆõA—Ž–

Îè@•Žu

“ú–{ƒTƒ‹ƒRƒCƒh[ƒVƒXE“÷‰èŽî«Ž¾Š³Šw‰ï

—Ž–

Îè@•Žu

ŒÄ‹zŠÇ—Šw‰ï

—Ž–

Îè@•Žu

“ú–{ŒÄ‹zŠÇ—Šw‰ï

—Ž–Eà–±ˆÏˆõ

Îè@•Žu

ƒAƒŒƒ‹ƒM[Šw‰ï

•]‹cˆõ

Îè@•Žu

“ú–{”xŠàŠw‰ï

•]‹cˆõ

Îè@•Žu

“ú–{ŒÄ‹zŠí“àŽ‹‹¾Šw‰ï

•]‹cˆõ(•ÒWˆÏˆõj

Îè@•Žu

•Ä‘S‘Ÿ•aŠw‰ï

”xzŠÂ•”–å•]‹cˆõ

Îè@•Žu

“ú–{ˆã—pƒ}ƒXƒXƒyƒNƒgƒ‹Šw‰ï

—Ž–

d¼@—z‰î

“ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ï

—Ž–

d¼@—z‰î

“ú–{æ“V‘ãŽÓˆÙíŠw‰ï

—Ž–

d¼@—z‰î

“ú–{¬Ž™“à•ª”åŠw‰ï

•]‹cˆõ

d¼@—z‰î

“ú–{¬Ž™‰ÈŠw‰ï

‘ã‹cˆõ

d¼@—z‰î

 

 

 

iCj      À’·

‘“àŠw‰ïi‘S‘ƒŒƒxƒ‹j

Šw‰ï–¼

Ž–¼

ƒVƒ“ƒ|ƒWƒEƒ€“™

“ú–{ŒÄ‹zŠíŠw‰ï

Îú±@•Žu

ƒVƒ“ƒ|ƒWƒEƒ€“™

“ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ

Îú±@•Žu

 

 

 

iDj      ŠwpŽGŽ“™‚Ì•ÒW

ŠwpŽGŽ“™‚Ì–¼Ì

ˆÏˆõ’·iŽå¸jEˆÏˆõ‚Ì•Ê

Ž–¼

JSBMS Letters

•ÒWˆÏˆõ

d¼@—z‰î

“ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ

•ÒWˆÏˆõ

d¼@—z‰î

 

 

 

iEj      ‚»‚Ì‘¼

ƒ•ñ“¹„

·   Îú±@•Žu: •ŸˆäŒ§‚ª‚ñŒŸf, •ŸˆäŒ§–¯‚É”xŠàŒŸf‚ðŠ©‚ß‚éŒ[”­DVD‚ð쬂µ‚à‚æ‚è‚ÌŒŸfƒZƒ“ƒ^[AŽs’¬‘º‚É”z•z‚µ‚½B, •ŸˆäŒ§, 2009.03.02

·   Îú±@•Žu: VŒ^ƒCƒ“ƒtƒ‹—\–hô‚Ì“O’ê‚ð, VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUŠ´õ‚É”õ‚¦AŒÂl‚łł«‚邱‚Æ‚ð‰ðà, •ŸˆäV•·, 2009.04.30

·   Îú±@•Žu: ‚RŽŸŒ³‰f‘œ‚ÅŠ³•”’ÇÕ@•Ÿˆä‘å•a‰@¬‰Ê‚ ‚°‚é, “Ç”„V•·, 2009.11.01

·   *ˆÀÖ@³Ž÷, Îú±@•Žu: ŒÄ‹zŠí‚Ì•a‹C@3ŽŸŒ³‰f‘œ‚ÅŠ³•”h’ÇÕh, “Ç”„V•·, 2009.11.01

·   Îú±@•Žu: ‚»‚ÌÇóA–{“–‚ÉuVŒ^vHu–Ɖu‚Å‚«‚½v–û’f‹Ö•¨, •—Ž×‚̃EƒCƒ‹ƒX‚Å‚àAƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Æ“¯‚¶‚悤‚ÈÇ󂪂łé‚à‚Ì‚ª‚ ‚é‚Ì‚ÅATd‚É”»’f‚ð‚·‚é•K—v‚ª‚ ‚é, •ŸˆäV•·, 2009.12.23

 

 

 

6D    ŽY‹ÆEŽÐ‰ï‚Ö‚ÌvŒ£

iAj      ‘E’nˆæ“™‚Ö‚ÌvŒ£

(1)    R‹c‰ïEˆÏˆõ‰ïEŒö‰v–@lE‰ïŽÐ“™‚Ö‚ÌŽQ‰Áó‹µ